期刊文献+

风云变幻的冠脉支架(跟踪报道) 被引量:1

下载PDF
导出
摘要 冠心病是冠状动脉粥样硬化性心脏病的简称,由于冠状动脉狭窄而引起心肌缺血、管腔狭窄,严重的会发生心肌梗死。冠心病由于其发病率、死亡率高,严重危害着人类的身体健康,被称为“人类的第一杀手”。随着生活水平的提高,生活节奏的加快及国民生活习惯的改变,冠心病的发病率呈增高趋势。
作者 袁启明
机构地区 本刊编辑部
出处 《生物医学工程学进展》 CAS 2008年第1期58-62,共5页 Progress in Biomedical Engineering
  • 相关文献

同被引文献23

  • 1He H, Shirota T, Yasui H, et al. Canine endothelial progenitor cell-lined hybrid vascular graft with non-thrombogenic potential. J Thorac Cardiovasc Surg,2003 ,126 :455-464.
  • 2Shirota T,He H, Yasui H, et al. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng,2003, 9 : 127-136.
  • 3Walter DH, Cejna M, Diaz-Sandoval L, et al. Local gene transfer of ph VEGF-2 plasmid by gene-eluting stents: an ahemative strategy for inhibition of restenosis. Circulation, 2004, 110 : 36- 45.
  • 4Mauri L,Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med, 2007,356 : 1020-1029.
  • 5James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in sweden. N Engl J Med,2009,360 : 1933-1945.
  • 6Ltischer TF,Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis : biological mechanisms and clinical implications. Circulation, 2007, 115 : 1051-1058.
  • 7Sketch MH Jr, Ball M, Rutherford B, et al. Evaluation of theMedtronic (Driver) cobah-chromium alloy coronary stent system. J Am J Cardiol, 2005, 95:82121.
  • 8Fajadet J,Wijns W, Laarman GJ, et al. Randomized, doubleblind, muhicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Circulation, 2006,114 :798-806.
  • 9Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paelitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA, 2008, 299 : 1903-1913.
  • 10AokiJ, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stent scoated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol, 2005,45:1574-1579.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部